Skip to content
← Back to this collection

PUBLICATIONS · 30420614

Derazantinib (ARQ 087) in advanced or inoperable FGFR2 gene fusion-positive intrahepatic cholangiocarcinoma.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Br J Cancer
Publication date
2019 Jan
First author
Mazzaferro V

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2019 Jan;20(1):e11. doi: 10.1016/S1470-2045(18)30891-X.
    note
    Source null
    related pmid
    30473470
    relationship
    Comment in

Authors and identifiers

  1. name
    Mazzaferro V
    type
    Author
  2. name
    El-Rayes BF
    type
    Author
  3. name
    Droz Dit Busset M
    type
    Author
  4. name
    Cotsoglou C
    type
    Author
  5. name
    Harris WP
    type
    Author
  6. name
    Damjanov N
    type
    Author
  7. name
    Masi G
    type
    Author
  8. name
    Rimassa L
    type
    Author
  9. name
    Personeni N
    type
    Author
  10. name
    Braiteh F
    type
    Author
  11. name
    Zagonel V
    type
    Author
  12. name
    Papadopoulos KP
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Mazzaferro V
    type
    Author
  2. name
    El-Rayes BF
    type
    Author
  3. name
    Droz Dit Busset M
    type
    Author
  4. name
    Cotsoglou C
    type
    Author
  5. name
    Harris WP
    type
    Author
  6. name
    Damjanov N
    type
    Author
  7. name
    Masi G
    type
    Author
  8. name
    Rimassa L
    type
    Author
  9. name
    Personeni N
    type
    Author
  10. name
    Braiteh F
    type
    Author
  11. name
    Zagonel V
    type
    Author
  12. name
    Papadopoulos KP
    type
    Author
bibliography ids
  1. nci-bib-d18db694360c883aeee08e50
book metadata
content sha256
daf953366c6701858e3a5372ec13cd3fec55e43739b040ce0f29a603f90a7cab
document type
citation
dois
  1. 10.1038/s41416-018-0334-0
electronic publication date
display
2018 Nov 13
precision
day
year
2018
evidence scope
bibliographic_metadata_only
id
pubmed:30420614
immutable id
pubmed:30420614@daf953366c6701858e3a5372ec13cd3fec55e43739b040ce0f29a603f90a7cab
journal
abbreviation
Br J Cancer
issn electronic
1532-1827
issn print
0007-0920
issue
2
name
British journal of cancer
nlm unique id
0370635
pages
165-171
volume
120
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2019 Jan;20(1):e11. doi: 10.1016/S1470-2045(18)30891-X.
    note
    Source null
    related pmid
    30473470
    relationship
    Comment in
outcomes validated
false
pmid
30420614
provenance
batch id
438b2803888025c6cf56
provider
NCBI PubMed ESummary
record sha256
04fe4ce313f7fe6c285cbb957860b259c45f47680f47d710356155071d224bb7
response sha256
0adf5ff07d3aa03a45feef5e4b7998e2ddea370eb9d1c6aa9134c5fd329767e6
retrieved at
2026-09-09T23:47:36.359220+00:00
publication date
display
2019 Jan
precision
month
year
2019
publication types
  1. Journal Article
  2. Clinical Trial, Phase II
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/30420614/
title
Derazantinib (ARQ 087) in advanced or inoperable FGFR2 gene fusion-positive intrahepatic cholangiocarcinoma.

Preserved source evidence · Not medical advice